Harbor Capital Advisors Inc. Raises Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Harbor Capital Advisors Inc. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 7,006 shares of the medical equipment provider’s stock after acquiring an additional 172 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in Intuitive Surgical were worth $3,657,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the business. Andra AP fonden purchased a new stake in Intuitive Surgical in the 2nd quarter valued at about $178,000. MGO One Seven LLC boosted its holdings in shares of Intuitive Surgical by 76.2% in the second quarter. MGO One Seven LLC now owns 4,090 shares of the medical equipment provider’s stock valued at $1,819,000 after purchasing an additional 1,769 shares during the period. LPL Financial LLC grew its stake in Intuitive Surgical by 9.2% in the second quarter. LPL Financial LLC now owns 294,740 shares of the medical equipment provider’s stock worth $131,115,000 after purchasing an additional 24,715 shares in the last quarter. Jupiter Asset Management Ltd. purchased a new position in Intuitive Surgical during the 2nd quarter worth $364,000. Finally, First Turn Management LLC bought a new stake in Intuitive Surgical during the 2nd quarter valued at $18,640,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is owned by insiders.

Intuitive Surgical Price Performance

Shares of ISRG opened at $547.47 on Friday. The firm has a market capitalization of $195.00 billion, a PE ratio of 88.02, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. The company’s fifty day moving average price is $535.93 and its 200-day moving average price is $494.44. Intuitive Surgical, Inc. has a 1-year low of $355.17 and a 1-year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.